Contraceptive Clinical Trials Network of the National Institutes of Health. This network was awarded in 2005 and renewed in 2013. The CCTN was established in 1996 to support research on male and female contraception and to conduct clinical trials of new contraceptive drugs and devices.
Maternal Fetal Medicine Units Network. The NICHD established the MFMU Network in 1986 to respond to the need for well-designed clinical trials in maternal- fetal medicine and obstetrics, particularly with respect to the continuing problem of preterm birth. The MFMU is funded through the NICHD’s Pregnancy and Perinatology Branch (PPB).
NRG Oncology is a non-profit research organization formed to conduct oncologic clinical research as a part of the National Cancer Institute’s National Clinical Trial Network. It combines the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG). One research focus of this group is genitourinary and gynecologic cancers.
Pelvic Floor Disorders Network. The PFDN was established in 2001 to encourage collaborative research on pelvic floor disorders, which affect as many as one third of U.S. women. The PFDN is composed of eight clinical centers and a Data Coordinating Center. The University of Pennsylvania was funded as a clinical center in 2011, and renewed in 2016.
Reproductive Medicine Network funded by NICHD. The Reproductive Medicine Network (RMN), established in 1990 and funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), is a cooperative effort of seven clinical sites, a data coordinating center, and the Fertility and Infertility (FI) Branch of the NICHD, charged with conducting and publishing high quality clinical studies in reproductive medicine.
Oncofertility Consortium. The Oncofertility Consortium® is a national, interdisciplinary initiative designed to explore the reproductive future of cancer survivors.